Quesenberry, Peter J.
Non-Hodgkin Lymphoma Prognostic Factors and Targets / [electronic resource] : edited by Peter J. Quesenberry, Jorge J. Castillo. - VI, 304 p. 15 illus., 11 illus. in color. online resource. - Cancer Drug Discovery and Development . - Cancer Drug Discovery and Development .
Cancer Stem Cells: A Matter of Perspective -- B and T-cell development -- HIV lymphomagenesis -- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets -- Antigen driven lymphomagenesis -- Pre-clinical lymphoma models -- Prognostic factors in B-cell lymphoma -- Prognostic factors in T-cell lymphoma -- Prognostic factors in HIV-associated lymphoma -- Future directions on the treatment of aggressive non-Hodgkin lymphoma -- New monoclonal antibodies for indolent non-Hodgkin lymphomas -- Current therapies for T-cell lymphoma -- Stem Cell Transplantation for lymphoma -- Autologous stem cell transplantation in non-Hodgkin lymphoma -- The role of Stem Cell Transplantation for HIV-associated lymphoma -- Stem Cell Transplantation for T-cell lymphoma -- Index.
Recent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin lymphoma provides a mean to improve its risk-stratification and treatment. This book is intended for medical and healthcare professionals involved in the research and clinical care of patients with non-Hodgkin lymphoma.
9781461458517
10.1007/978-1-4614-5851-7 doi
Medicine.
Oncology.
Toxicology.
Biomedicine.
Cancer Research.
Pharmacology/Toxicology.
RC261-271
614.5999
Non-Hodgkin Lymphoma Prognostic Factors and Targets / [electronic resource] : edited by Peter J. Quesenberry, Jorge J. Castillo. - VI, 304 p. 15 illus., 11 illus. in color. online resource. - Cancer Drug Discovery and Development . - Cancer Drug Discovery and Development .
Cancer Stem Cells: A Matter of Perspective -- B and T-cell development -- HIV lymphomagenesis -- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets -- Antigen driven lymphomagenesis -- Pre-clinical lymphoma models -- Prognostic factors in B-cell lymphoma -- Prognostic factors in T-cell lymphoma -- Prognostic factors in HIV-associated lymphoma -- Future directions on the treatment of aggressive non-Hodgkin lymphoma -- New monoclonal antibodies for indolent non-Hodgkin lymphomas -- Current therapies for T-cell lymphoma -- Stem Cell Transplantation for lymphoma -- Autologous stem cell transplantation in non-Hodgkin lymphoma -- The role of Stem Cell Transplantation for HIV-associated lymphoma -- Stem Cell Transplantation for T-cell lymphoma -- Index.
Recent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin lymphoma provides a mean to improve its risk-stratification and treatment. This book is intended for medical and healthcare professionals involved in the research and clinical care of patients with non-Hodgkin lymphoma.
9781461458517
10.1007/978-1-4614-5851-7 doi
Medicine.
Oncology.
Toxicology.
Biomedicine.
Cancer Research.
Pharmacology/Toxicology.
RC261-271
614.5999